PreprintCited by 32Monoclonal and Polyclonal Antibodies Researchvaccines and immunoinformatics approachesComputational Drug Discovery Methods

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

AB-Gen: Antibody Library Design with Generative Pre-trained Transformer and Deep Reinforcement Learning

Open access
Xu, Xiaopeng, Xu, Tiantian, Zhou, Juexiao, Liao, Xingyu, Zhang, Ruochi, Wang, Yu, Zhang, Lu, Gao, Xin·2023·Genomics Proteomics & Bioinformatics

Preprint — published as 10.1016/j.gpb.2023.03.004 · Paper page

Abstract

Antibody leads must fulfill multiple desirable properties to be clinical candidates. Primarily due to the low throughput in the experimental procedure, the need for such multi-property optimization causes the bottleneck in preclinical antibody discovery and development, because addressing one issue usually causes another. We developed a reinforcement learning (RL) method, named AB-Gen, for antibody library design using a generative pre-trained Transformer (GPT) as the policy network of the RL agent. We showed that this model can learn the antibody space of heavy chain complementarity determining region 3 (CDRH3) and generate sequences with similar property distributions. Besides, when using HER2 as the target, the agent model of AB-Gen was able to generate novel CDRH3 sequences that fulfill multi-property constraints. 509 generated sequences were able to pass all property filters and three highly conserved residues were identified. The importance of these residues was further demonstrated by molecular dynamics simulations, which consolidated that the agent model was capable of grasping important information in this complex optimization task. Overall, the AB-Gen method is able to design novel antibody sequences with an improved success rate than the traditional propose-then-filter approach. It has the potential to be used in practical antibody design, thus empowering the antibody discovery and development process.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2023.03.17.533102

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 32

  1. 10.1369/jhc.2008.952770 · DOI
  2. 2018, A mini-review and perspective on multicyclic peptide mimics of antibodies, Chinese Chemical Letters, 29, 1063, 10.1016/j.cclet.2018.03.015 · DOI
  3. 10.1038/nrd3078 · DOI · Paper page
  4. 10.1073/pnas.1421779112 · DOI
  5. 2022, Structure-based optimizations of a necroptosis inhibitor (szm594) as novel protective agents of acute lung injury, Chinese Chemical Letters, 33, 2545, 10.1016/j.cclet.2021.09.059 · DOI
  6. 2021, Optimization of therapeutic antibodies by predicting antigen specificity from antibody sequence via deep learning, Nature Biomedical Engineering, 5, 600, 10.1038/s41551-021-00699-9 · DOI · Paper page
  7. 10.1038/nature19946 · DOI · Paper page
  8. Xingjie Pan and Tanja Kortemme . Recent advances in de novo protein design: principles, methods, and applications. Journal of Biological Chemistry, 296, 2021. · DOI
  9. 10.1126/science.abn2100 · DOI · Paper page
  10. 2021, De novo protein design by deep network hallucination, Nature, 600, 547, 10.1038/s41586-021-04184-w · DOI · Paper page
  11. 2021, Protein design and variant prediction using autoregressive generative models, Nature Communications, 12, 1
  12. 10.1162/neco.1997.9.8.1735 · DOI · Paper page
  13. 2022, MAbs, 14, 2031482
  14. Ashish Vaswani , Noam Shazeer , Niki Parmar , Jakob Uszkoreit , Llion Jones , Aidan N Gomez , Lukasz Kaiser , and Illia Polosukhin . Attention is all you need. In Advances in Neural Information Processing Systems, pages 5998–6008, 2017.
  15. Richard W Shuai , Jeffrey A Ruffolo , and Jeffrey J Gray . Generative language modeling for antibody design. bioRxiv, 2021. · DOI
  16. 2019, Language models are unsupervised multitask learners, OpenAI blog, 1, 9
  17. 2022, MAbs, 14, 2020203
  18. Tobias H Olsen , Fergus Boyles , and Charlotte M Deane . Observed antibody space: a diverse database of cleaned, annotated, and translated unpaired and paired antibody sequences. Protein Science, 2021. · DOI · Paper page
  19. 2020, Netmhcpan-4.1 and netmhciipan4.0: improved predictions of mhc antigen presentation by concurrent motif deconvolution and integration of ms mhc eluted ligand data, Nucleic Acids Research, 48, W449, 10.1093/nar/gkaa379 · DOI · Paper page
  20. 10.1016/s0145-305x(02)00039-3 · DOI
  21. 2011, Pandas: a foundational python library for data analysis and statistics, Python for High Performance and Scientific Computing, 14, 1
  22. 2017, Molecular de-novo design through deep reinforcement learning, Journal of Cheminformatics, 9, 1
  23. 10.1016/j.jmb.2014.09.026 · DOI · Paper page
  24. Julie D Thompson , Toby J Gibson , and Des G Higgins . Multiple sequence alignment using clustalw and clustalx. Current Protocols in Bioinformatics, (1):2–3, 2003. · DOI
  25. 10.1101/gr.849004 · DOI
  26. 10.1038/nature01392 · DOI
  27. 2019, Structural insight into a matured humanized monoclonal antibody hua21 against her2-overexpressing cancer cells, Acta Crystallographica Section D: Structural Biology, 75, 554, 10.1107/S2059798319006995 · DOI
  28. 10.1021/acs.jctc.5b00255 · DOI
  29. 10.1016/j.softx.2015.06.001 · DOI · Paper page
  30. Philippe A. Robert , Rahmad Akbar , Robert Frank , Milena Pavlović , Michael Widrich , Igor Snapkov , Andrei Slabodkin , Maria Chernigovskaya , Lonneke Scheffer , Eva Smorodina , Puneet Rawat , Brij Bhushan Mehta , Mai Ha Vu , Ingvild Frøberg Mathisen , Aurél Prósz , Krzysztof Abram , Alex Olar , Enkelejda Miho , Dag Trygve Tryslew Haug , Fridtjof Lund-Johansen , Sepp Hochreiter , Ingrid Hobæk Haff , Günter Klambauer , Geir Kjetil Sandve , and Victor Greiff . Unconstrained generation of synthetic antibody-antigen structures to guide machine learning methodology for real-world antibody specificity prediction. BioRxiv, 2022. · DOI
  31. 2020, Computational approaches to therapeutic antibody design: established methods and emerging trends, Briefings in Bioinformatics, 21, 1549, 10.1093/bib/bbz095 · DOI · Paper page
  32. 2022, In MAbs, 14, 2008790

Metadata

Authors
Xu, X., Xu, T., Zhou, J., Liao, X., Zhang, R., Wang, Y., Zhang, L., & Gao, X.
Affiliations
  • King Abdullah University of Science and Technology (SA)
  • Chinese Academy of Sciences (CN)
Corresponding author
Gao, Xin
Venue
Genomics Proteomics & Bioinformatics
Publisher
openRxiv
Published
2023-03-21
Volume
21
Issue
5
Pages
1043-1053
ISSN
1672-0229 (ISSN-L)
OpenAlex
W4381848602
Cited by
32
References
1
Citations by year
2026: 14 · 2025: 10 · 2024: 6 · 2023: 2
FWCI
5.44
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Genomics Proteomics & Bioinformatics (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • King Abdullah University of Science and Technology Repository (King Abdullah University of Science and Technology) (submittedVersion, cc-by-nc-nd)
Funders
  • National Natural Science Foundation of China (22273107)
  • King Abdullah University of Science and Technology (FCC/1/1976- 45-01, URF/1/4352–01-01, FCC/1/1976‐44‐01, REI/1/5234-01-01)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
Keywords
generative pre-trained transformer, deep reinforcement learning, multi-property optimization, HER2, antibody discovery, molecular dynamics, conserved residues
MeSH terms
Antibodies, Humans, Software, Gene Library, Molecular Dynamics Simulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review